Navigation Links
Boston University Medical Center researcher honored
Date:12/13/2007

Boston, MAMichael F. Holick, PhD, MD, was recently awarded the 2007 Eli Lilly Lecturer Award from the Canadian Society of Endocrinology and Metabolism (CSEM). Holick, an internationally recognized expert in vitamin D and skin research, received the award for decades of pioneering work that elucidated the important role vitamin D plays in a wide variety of chronic health conditions.

Holick is a professor of medicine, physiology, and biophysics, and director of the General Clinical Research Center at Boston University School of Medicine and Director of the Bone Healthcare Clinic at Boston Medical Center.

The Eli Lilly Lecturer Award has been awarded to some of the most prominent endocrinologists in the world. CSEM represents over three hundred endocrinologists engaged in basic research or clinical practice in communities, universities and industries across Canada. They also represent the interests of their members with respect to clinical practice, academic training, research funding and medical politics.

After completing medical school at the University of Wisconsin in 1976, Holick joined the staff at the Massachusetts General Hospital where he did an internship in medicine while simultaneously initiating a basic and clinical research program on the photobiology of vitamin D. Over the next several years he made major contributions in the areas of skin disease, metabolic bone disease, and calcium metabolism.

In 1987, Holick was recruited by Boston University School of Medicine for the position of chief of endocrinology at Boston City Hospital and director of the Clinical Research Center. Since assuming this position, he has initiated numerous clinical research programs. His psoriasis work with active vitamin D is considered to be on the forefront of research into this complex disease. The results of these programs have led to significant contributions in the basic science of vitamin D and more recently into a clearer understanding of the calciotropic hormone, PTHrP and its uses. This translates into remarkable new therapies for a wide diversity of diseases from psoriasis and hair loss to osteoporosis.

Holick has received numerous honors and awards including The American Society for Clinical Nutritions McCollum Award for his innovative research in the field of photobiology in 1994, and the Psoriasis Research Achievement Award, American Skin Association in 2000, the Robert H. Herman Memorial Award in Clinical Nutrition, American Society for Clinical Nutrition 2002, and the General Clinical Research Centers Program Award for Excellence in Clinical Research in 2006 and the Functional Medicine Linus Pauling Award in 2007.


'/>"/>

Contact: Michelle Roberts
michelle.roberts@bmc.org
617-638-8491
Boston University
Source:Eurekalert

Related medicine news :

1. Boston Micromachines Multi-DM Named One of the Years Most Innovative Products
2. Boston University School of Medicine researcher recipient of Memory Ride Grant
3. Success of Shape-Up Somerville Childhood Obesity Intervention to be Presented at the Friedman School Symposium at Tufts, October 29-31, 2007 - Boston
4. AAHFNs 2008 Annual Meeting in Boston Will Be Raising the Bar in Heart Failure Care
5. Families Invited to Celebrate Shire Day at Boston Childrens Museum
6. Boston Scientific Announces Amended Agreement to Settle Product Lawsuits
7. Boston Scientific Announces New Initiatives to Increase Shareholder Value
8. Boston Scientific Announces Additions to Clinical Sciences Organization
9. Boston University School of Medicine physician receives award from AATOD
10. Boston Scientific Announces Verdict in Cordis Litigation
11. Boston Scientific Announces Sale of Cardiac Surgery and Vascular Surgery Businesses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... ... has seen a significant spike in their clients' employee participation for their wellness ... health screening by implementing a high-deductible health plan with outcome-based deductible incentives. As ...
(Date:5/25/2016)... ... , ... Stern Environmental Group , of Secaucus, New Jersey, working in ... Stern’s Real Time Monitoring (RTM) Device. Stern Environmental Group will sell the first ... for use in dormitories, shelters, and nursing homes for real time bedbug monitoring in ...
(Date:5/24/2016)... Milwaukee, WI (PRWEB) , ... May 24, 2016 ... ... has announced that Rudolfo (Rudy) Cifolelli has joined the company as Vice President ... and the development of U.S. and international sales in the rapidly expanding field ...
(Date:5/24/2016)... ... ... Jericho Project has named LaToya Williams-Belfort to the position of Chief Development and Communications ... the nationally-acclaimed nonprofit, working closely with CEO Tori Lyon and the Board of Directors ... , “LaToya Williams-Belfort is joining Jericho at an exciting time of growth and ...
(Date:5/24/2016)... ... 24, 2016 , ... How to Write Error Free Procedures, **Presented by Ginette ... Human error is known to be the major cause of quality and production losses ... eliminated, many human performance problems can be prevented. , How to Write Error Free ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... Non-invasive diagnostic test realizes the potential of ... be presented at Yissum’s booth, at IATI-BIOMED 2016 conference  ... the Hebrew University of Jerusalem announced today it ... MKI, the technology investment arm of Morris Kahn , ... early detection of multiple diseases by analyzing circulating DNA ...
(Date:5/23/2016)... May 23, 2016 Gamida Cell, ... treatment of cancer and orphan genetic diseases, announced today ... $4.4 million from the Israel Innovation Authority (formerly the ... of Economy and Industry. The mission of the Israel ... various industries, including science and technology, while stimulating economic ...
(Date:5/23/2016)... Conn. , May 23, 2016   ... has entered into an agreement with Egalet Corporation ... patent claims. As part of the agreement the ... and will enable all three companies to develop ... properties. "This agreement reflects the commitment ...
Breaking Medicine Technology: